Back
Kymera Therapeutics Vs. Denali Therapeutics Industry Stock Comparison
Sell
39
KYMR
Kymera Therapeutics
Last Price:
$40.66
Seasonality Move:
2.79%
Sell
6
DNLI
Denali Therapeutics
Last Price:
$21.48
Seasonality Move:
-13.89%
Sell
39
Kymera Therapeutics (KYMR)
is a Sell
Is Kymera Therapeutics a Buy, Sell or Hold?
-
The current Kymera Therapeutics [KYMR] share price is $40.64. The Score for KYMR is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
-
KYMR is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
6
Denali Therapeutics (DNLI)
is a Sell
Is Denali Therapeutics a Buy, Sell or Hold?
-
The current Denali Therapeutics [DNLI] share price is $21.46. The Score for DNLI is 6, which is 88% below its historic median score of 50, and infers higher risk than normal.
-
DNLI is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing an extreme reading that indicates risk could be especially high.
KYMR Stock Price Chart
What is Kymera Therapeutics's stock price today?
-
The Kymera Therapeutics share price today is $40.64Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and KYMR is experiencing buying pressure, which is a positive indicator for future bullish movement.
DNLI Stock Price Chart
What is Denali Therapeutics's stock price today?
-
The Denali Therapeutics share price today is $21.46Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and DNLI is experiencing slight selling pressure.
KYMR Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -1.61 | Sell |
Relative Strength Index (14 RSI): | 40.07 | Sell |
Chaikin Money Flow: | 1023886 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (41.59 - 46.41) | Sell |
Bollinger Bands (100): | (42.92 - 48.78) | Sell |
DNLI Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -1.18 | Sell |
Relative Strength Index (14 RSI): | 31.49 | Sell |
Chaikin Money Flow: | -592505 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (22.8 - 25.06) | Sell |
Bollinger Bands (100): | (23.29 - 28.63) | Sell |
KYMR Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 41.68 | Sell |
20-day SMA: | 44.26 | Sell |
50-day SMA: | 45.89 | Sell |
200-day SMA: | 41.31 | Sell |
8-day EMA: | 41.51 | Sell |
20-day EMA: | 43.39 | Sell |
50-day EMA: | 44.87 | Sell |
200-day EMA: | 41.09 | Sell |
DNLI Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 22.65 | Sell |
20-day SMA: | 23.81 | Sell |
50-day SMA: | 25.85 | Sell |
200-day SMA: | 23.06 | Sell |
8-day EMA: | 22.5 | Sell |
20-day EMA: | 23.71 | Sell |
50-day EMA: | 25.1 | Sell |
200-day EMA: | 24.11 | Sell |
Kymera Therapeutics Earnings Growth & KYMR Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.03 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.12 per share, and a decrease next year of $0.37 per share.
Denali Therapeutics Earnings Growth & DNLI Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.09 per share, a decrease next quarter of $0.00 per share, a decrease this year of $1.84 per share, and a decrease next year of $0.15 per share.
Kymera Therapeutics Technical Analysis
Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | ||||||||||
09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Denali Therapeutics Technical Analysis
Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | ||||||||||
09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |